Alzheimer'S Disease Clinical Trials in Phoenix, AZ

Alzheimer'S Disease Clinical Trials in Phoenix, AZ

View the best 10 alzheimer's disease medical studies in Phoenix, Arizona. Access promising new therapies by applying to a Phoenix-based Alzheimer'S Disease clinical trial.

Trials in Phoenix, Arizona

Here are the top 10 medical studies for alzheimer's disease in Phoenix, Arizona

Michael Bask Gill, B Sc preview

Michael Bask Gill, B Sc

Last Reviewed: March 21st, 2025

Image of Arizona State University, College of Health Solutions in Phoenix, United States.

Time Restricted Eating

Behavioral Intervention

Recruiting1 award1 criteria
This trial will test whether a specific eating schedule, where participants fast for 16 hours and eat within an 8-hour window on 5 days a week for 3 months, is feasible and beneficial
Image of Location - 001 in Princeton, United States.

KarXT

Behavioural Intervention

Recruiting1 awardPhase 3
This trial aims to test the safety and effectiveness of KarXT in adults with Alzheimer's Disease who also have psychosis.
Image of Banner University Medical Center in Phoenix, United States.

AV-1959

Cancer Vaccine

Recruiting0 awardsPhase 1
This trial tests a vaccine to prevent Alzheimer's Disease.
Image of Galiz Research in Hialeah, United States.

[18F]PI-2620

PET Imaging Agent

Recruiting2 awardsPhase 3
This trial tests a brain scan that uses a special substance to detect harmful proteins in people with Alzheimer's disease.
Image of Voyage Medical in Tempe, United States.

SPARK Test

Software

Recruiting1 award3 criteria
This trial uses a software to study patients' brainwaves to see if it's effective.
Image of Noah Clinical Site 017 in Scottsdale, United States.

Polypill

Fixed Dose Combination

Recruiting0 awardsPhase 2
This trial aims to see how well a combination drug called a polypill works for patients with Alzheimer's Disease over 180 days. They will include male and female patients aged 50-85 with
Image of Clinical Research Site in Peoria, United States.

AXS-05

Behavioural Intervention

Recruiting2 awardsPhase 3
This trial will assess the safety of AXS-05 over a long period for treating agitation in Alzheimer's patients who were in two previous studies.
Image of Banner Sun Health Research Institute in Sun City, United States.

Lecanemab

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial aims to find out how different doses of E2814, when given at the same time as lecanemab, affect the levels of a specific protein in the cerebrospinal fluid
Image of Ah0003 50423 in East Providence, United States.

Bepranemab

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial is testing bepranemab, a new medication, to see if it can help people with early-stage Alzheimer's disease. The study focuses on individuals who are just starting to show symptoms or have mild symptoms. Bepranemab works by removing harmful proteins from the brain that are linked to Alzheimer's.
Image of Sunwise Clinical Research in Walnut Creek, United States.

NMRA-323511

Behavioural Intervention

Recruiting0 awardsPhase 1
This trial has two parts, Part A and Part B. Part A is focused on testing the safety, tolerability, and how the body processes a drug called NMRA-323511 in healthy

Popular Filters

Age 65+
Phase 3
< 50 mile distance
No Placebo

Phase 3 Trials

Princeton, New Jersey

Behavioural Intervention

KarXT for Psychosis in Alzheimer's Disease

Recruiting1 awardPhase 3
Phoenix, Arizona
This trial aims to test the safety and effectiveness of KarXT in adults with Alzheimer's Disease who also have psychosis.
Hialeah, Florida

PET Imaging Agent

[18F]PI-2620 PET Imaging for Alzheimer's Disease

Recruiting2 awardsPhase 3
Phoenix, Arizona
This trial tests a brain scan that uses a special substance to detect harmful proteins in people with Alzheimer's disease.
Covina, California

Monoclonal Antibodies

Donanemab for Alzheimer's Disease

Recruiting1 awardPhase 3
Phoenix, Arizona
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Peoria, Arizona

Behavioural Intervention

AXS-05 for Alzheimer's Disease Agitation

Recruiting2 awardsPhase 3
Peoria, Arizona
This trial will assess the safety of AXS-05 over a long period for treating agitation in Alzheimer's patients who were in two previous studies.
Phoenix, Arizona

Anti-amyloid agent

ALZ-801 for Early Alzheimer's Disease

Recruiting2 awardsPhase 3
Phoenix, Arizona
"This trial is looking at how safe and effective ALZ-801 is for people with Early Alzheimer's disease who have a specific genetic marker. Participants will receive treatment with ALZ-801 in an open
Spokane, Washington

AR1001 for Alzheimer's Disease

Recruiting1 awardPhase 3
Phoenix, Arizona
This trial tests AR1001, a medicine for early Alzheimer's Disease. It focuses on people in the early stages of Alzheimer's, aiming to improve their condition through multiple mechanisms.

Trials With No Placebo

Phoenix, Arizona

Behavioral Intervention

Intermittent Fasting for Alzheimer's Disease

Recruiting1 award1 criteria
Phoenix, Arizona
This trial will test whether a specific eating schedule, where participants fast for 16 hours and eat within an 8-hour window on 5 days a week for 3 months, is feasible and beneficial
Phoenix, Arizona

Behavioural Intervention

Sensory Stimulation for Alzheimer's Disease

Recruiting1 award
Phoenix, Arizona
This trial is an extension of a previous study where participants will receive treatment with an Active Sensory Stimulation System for up to 12 months. There will be no sham treatment or randomization in this
Hialeah, Florida

PET Imaging Agent

[18F]PI-2620 PET Imaging for Alzheimer's Disease

Recruiting2 awardsPhase 3
Phoenix, Arizona
This trial tests a brain scan that uses a special substance to detect harmful proteins in people with Alzheimer's disease.
Peoria, Arizona

Behavioural Intervention

AXS-05 for Alzheimer's Disease Agitation

Recruiting2 awardsPhase 3
Peoria, Arizona
This trial will assess the safety of AXS-05 over a long period for treating agitation in Alzheimer's patients who were in two previous studies.
Phoenix, Arizona

Anti-amyloid agent

ALZ-801 for Early Alzheimer's Disease

Recruiting2 awardsPhase 3
Phoenix, Arizona
"This trial is looking at how safe and effective ALZ-801 is for people with Early Alzheimer's disease who have a specific genetic marker. Participants will receive treatment with ALZ-801 in an open
Tampa, Florida

Behavioural Intervention

Cognitive Training for Alzheimer's Disease

Recruiting2 awardsPhase 3
Phoenix, Arizona
This trial will test if a cognitive training technique can help delay the onset of mild cognitive impairment or dementia.

View More Related Trials

BMS-986446

Placebo +1 More

ACI-24.060

ABBV-916

AVP-786

Donanemab

Lecanemab

Mevidalen

ACU193

KarXT

Placebo +1 More

Bepranemab

Semaglutide +1 More

Escitalopram

Benfotiamine

Placebo +1 More

Moderate Intensity Continuous Training (MICT) +1 More

Donanemab

Placebo +2 More

SPARK Test

BIIB080

Semaglutide

Placebo +1 More

Lenalidomide

View more alzheimer's-disease clinical trials phoenix

See more medical studies focusing on alzheimer's-disease phoenix

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top